Download in electronic PDF format for $25

Kalchem International - Chemicals and Compounding Supplies

Search the Complete Journal Archives

Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations

Author(s):  Jasti Bhaskara R, Saraf Poonam

Issue:  May/Jun 2011 - Volume 15, Number 3
View All Articles in Issue

Abstract:  The compatibility of furosemide with 17 secondary drugs was studied to determine suitability for Y-site coadministration of the drug combinations. The drugs were tested at their standardized concentrations by visual observation for signs of physical incompatibilities. The secondary drugs were either tested undiluted or diluted in 5% dextrose injection or 0.9% sodium chloride injection as specified. Furosemide (10 mg/mL) was mixed with each of the secondary drugs in equal volume, and the mixture was observed for precipitation and turbidity visible to the unaided eye at 0, 4, and 24 hours after mixing. The pH was monitored over 24 hours for any significant fluctuations. The stability of furosemide was determined in combination with sodium bicarbonate over a 24-hour duration by quantifying, using spectophotometric measurements at the wavelength of 278 nm. Of the 17 secondary drugs evaluated, seven drugs showed incompatibility with furosemide resulting in the formation of gross turbid precipitates upon mixing. Dopamine hydrochloride and magnesium sulfate did not show instantaneous physical incompatibility but showed drug precipitation between 0 to 4 hours. The pH measurements did not show any significant changes in the studied drug combinations. The stability of furosemide with sodium bicarbonate at the tested standard concentrations was established since the concentrations measured up to 24 hours were within 10% of the initial value. Thus furosemide is unsuitable for Y-site coadministration with amiodarone hydrochloride, esmolol hydrochloride, labetalol hydrochloride, dobutamine hydrochloride, diltiazem hydrochloride, dopamine hydrochloride, and magnesium sulfate at their standardized concentrations. Coadministration of furosemide with sodium bicarbonate, norepinephrine bitartrate, phenylephrine hydrochloride, calcium gluconate, procainamide hydrochloride, nitroglycerin, epinephrine hydrochloride, heparin sodium, vasopressin, and insulin, at the standardized concentration, was found to be compatible.

Related Keywords: Bhaskara R. Jasti, PhD, Poonam Saraf, furosemide, parenteral preparations, intravenous administration, compatibility, drug mixtures

Related Categories: INFUSION, PARENTERALS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Jasti Bhaskara R, Saraf Poonam May/Jun 2011 259-261 Buy
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A Sep/Oct 2007 426-432 Buy
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher Jul/Aug 2002 311-315 Buy
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Rice Stephen P Mar/Apr 2002 120-122 Buy
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A May/Jun 2008 276-278 Buy
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel Jan/Feb 2009 78-80 Buy
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Wu George, Yeung Stanley, Chen Frank Jan/Feb 2017 76-82 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly Jan/Feb 2018 86-94 Buy
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P May/Jun 2002 230-233 Buy